{"id":170880,"date":"2026-06-09T13:50:40","date_gmt":"2026-06-09T13:50:40","guid":{"rendered":"https:\/\/www.m3globalresearch.com\/blog\/?p=170880"},"modified":"2026-06-09T13:50:44","modified_gmt":"2026-06-09T13:50:44","slug":"arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations","status":"publish","type":"post","link":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/","title":{"rendered":"ARB-Based Regimens Most Tolerated in Largest Comparison of Antihypertensive Drug Combinations"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n \t\t
\n\t\t\t\t\t\t\t\t\t

A large network meta-analysis published in JAMA has ranked antihypertensive drug combinations by tolerability, finding that regimens containing angiotensin II receptor blockers (ARBs) were the best tolerated, with lower rates of treatment discontinuation due to side effects than even placebo. The analysis involved 159,362 participants across 716 double-blind randomised controlled trials of at least four weeks duration.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Approximately 1.4 billion people were living with hypertension globally in 2024, according to the WHO, yet fewer than one in five have the condition adequately controlled. Poor tolerability is a recognised barrier to adherence, with studies estimating that between 30% and 80% of patients newly prescribed antihypertensive medication discontinue treatment within the first year. Common reasons include headaches, dizziness, peripheral oedema, and cough.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Using network meta-analysis and SUCRA (Surface Under the Cumulative Ranking Curve) statistical modelling, researchers were able to rank treatments that had not been directly compared in the same trials. ARBs featured in four of the five best-tolerated treatment options. The combination of an ARB with a calcium channel blocker (CCB) was the most tolerated pairing overall. CCBs used as monotherapy were significantly more likely to lead to treatment discontinuation. Combinations of a beta-blocker with a diuretic were also associated with higher discontinuation rates.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

An additional finding was that most antihypertensive agents, except CCBs, were associated with fewer headaches than placebo, possibly because CCBs promote cerebral vasodilation, which may itself trigger headache.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

The authors note that current pharmacological imaging tools do not provide sufficient resolution to make this distinction, and suggest that SSP could inform the design of future trials by identifying structural barriers to drug efficacy earlier in the development process.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

Source: Wang N et al. Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations. JAMA (2026). DOI: 10.1001\/jama.2026.6214<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\n<\/div>\n\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Researchers reveal how stromal barriers affect antibody-based therapies, mapping solid tumours at single-cell resolution.<\/p>\n","protected":false},"author":4,"featured_media":170885,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_eb_attr":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[3200],"tags":[8285],"class_list":["post-170880","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-medical-news","tag-hematology"],"acf":[],"yoast_head":"\nARB-Based Regimens Most Tolerated in Largest Comparison of Antihypertensive Drug Combinations<\/title>\n<meta name=\"description\" content=\"ARB-based regimens with angiotensin ii blockers ranked best tolerated in randomised controlled trials, showing fewer side-effect dropouts.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ARB-Based Regimens Most Tolerated in Largest Comparison of Antihypertensive Drug Combinations\" \/>\n<meta property=\"og:description\" content=\"ARB-based regimens with angiotensin ii blockers ranked best tolerated in randomised controlled trials, showing fewer side-effect dropouts.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/\" \/>\n<meta property=\"og:site_name\" content=\"M3 Global Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/en-gb.facebook.com\/M3GlobalResearch\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-09T13:50:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-09T13:50:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ARB-Based-Regimens-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Simone Guglielmi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@M3GR_Community\" \/>\n<meta name=\"twitter:site\" content=\"@M3GR_Community\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Simone Guglielmi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/\"},\"author\":{\"name\":\"Simone Guglielmi\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/person\\\/1cfdc9643db265062879b6101de95df0\"},\"headline\":\"ARB-Based Regimens Most Tolerated in Largest Comparison of Antihypertensive Drug Combinations\",\"datePublished\":\"2026-06-09T13:50:40+00:00\",\"dateModified\":\"2026-06-09T13:50:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/\"},\"wordCount\":295,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ARB-Based-Regimens-scaled.jpeg\",\"keywords\":[\"hematology\"],\"articleSection\":[\"Latest Medical News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/#respond\"]}]},{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/\",\"name\":\"ARB-Based Regimens Most Tolerated in Largest Comparison of Antihypertensive Drug Combinations\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ARB-Based-Regimens-scaled.jpeg\",\"datePublished\":\"2026-06-09T13:50:40+00:00\",\"dateModified\":\"2026-06-09T13:50:44+00:00\",\"description\":\"ARB-based regimens with angiotensin ii blockers ranked best tolerated in randomised controlled trials, showing fewer side-effect dropouts.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ARB-Based-Regimens-scaled.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/ARB-Based-Regimens-scaled.jpeg\",\"width\":2560,\"height\":1707,\"caption\":\"ARB-based regimens with angiotensin ii blockers ranked best tolerated in randomised controlled trials, showing fewer side-effect dropouts.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ARB-Based Regimens Most Tolerated in Largest Comparison of Antihypertensive Drug Combinations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\",\"name\":\"M3 Global Research\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\",\"name\":\"M3 Global Research\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":null,\"contentUrl\":null,\"width\":null,\"height\":null,\"caption\":\"M3 Global Research\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/en-gb.facebook.com\\\/M3GlobalResearch\\\/\",\"https:\\\/\\\/x.com\\\/M3GR_Community\",\"https:\\\/\\\/www.instagram.com\\\/m3globalresearch\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/10557915\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/person\\\/1cfdc9643db265062879b6101de95df0\",\"name\":\"Simone Guglielmi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/543a9507853330062cbff3a8ec7fdac833526c6115036f399b3123cb017b7d1a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/543a9507853330062cbff3a8ec7fdac833526c6115036f399b3123cb017b7d1a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/543a9507853330062cbff3a8ec7fdac833526c6115036f399b3123cb017b7d1a?s=96&d=mm&r=g\",\"caption\":\"Simone Guglielmi\"},\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/author\\\/sguglielmim3mr-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ARB-Based Regimens Most Tolerated in Largest Comparison of Antihypertensive Drug Combinations","description":"ARB-based regimens with angiotensin ii blockers ranked best tolerated in randomised controlled trials, showing fewer side-effect dropouts.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/","og_locale":"en_US","og_type":"article","og_title":"ARB-Based Regimens Most Tolerated in Largest Comparison of Antihypertensive Drug Combinations","og_description":"ARB-based regimens with angiotensin ii blockers ranked best tolerated in randomised controlled trials, showing fewer side-effect dropouts.","og_url":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/","og_site_name":"M3 Global Research","article_publisher":"https:\/\/en-gb.facebook.com\/M3GlobalResearch\/","article_published_time":"2026-06-09T13:50:40+00:00","article_modified_time":"2026-06-09T13:50:44+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ARB-Based-Regimens-scaled.jpeg","type":"image\/jpeg"}],"author":"Simone Guglielmi","twitter_card":"summary_large_image","twitter_creator":"@M3GR_Community","twitter_site":"@M3GR_Community","twitter_misc":{"Written by":"Simone Guglielmi","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/#article","isPartOf":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/"},"author":{"name":"Simone Guglielmi","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/person\/1cfdc9643db265062879b6101de95df0"},"headline":"ARB-Based Regimens Most Tolerated in Largest Comparison of Antihypertensive Drug Combinations","datePublished":"2026-06-09T13:50:40+00:00","dateModified":"2026-06-09T13:50:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/"},"wordCount":295,"commentCount":0,"publisher":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ARB-Based-Regimens-scaled.jpeg","keywords":["hematology"],"articleSection":["Latest Medical News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/#respond"]}]},{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/","url":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/","name":"ARB-Based Regimens Most Tolerated in Largest Comparison of Antihypertensive Drug Combinations","isPartOf":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/#primaryimage"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ARB-Based-Regimens-scaled.jpeg","datePublished":"2026-06-09T13:50:40+00:00","dateModified":"2026-06-09T13:50:44+00:00","description":"ARB-based regimens with angiotensin ii blockers ranked best tolerated in randomised controlled trials, showing fewer side-effect dropouts.","breadcrumb":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/#primaryimage","url":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ARB-Based-Regimens-scaled.jpeg","contentUrl":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ARB-Based-Regimens-scaled.jpeg","width":2560,"height":1707,"caption":"ARB-based regimens with angiotensin ii blockers ranked best tolerated in randomised controlled trials, showing fewer side-effect dropouts."},{"@type":"BreadcrumbList","@id":"https:\/\/www.m3globalresearch.com\/blog\/arb-based-regimens-most-tolerated-in-largest-comparison-of-antihypertensive-drug-combinations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.m3globalresearch.com\/blog\/"},{"@type":"ListItem","position":2,"name":"ARB-Based Regimens Most Tolerated in Largest Comparison of Antihypertensive Drug Combinations"}]},{"@type":"WebSite","@id":"https:\/\/www.m3globalresearch.com\/blog\/#website","url":"https:\/\/www.m3globalresearch.com\/blog\/","name":"M3 Global Research","description":"","publisher":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.m3globalresearch.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization","name":"M3 Global Research","url":"https:\/\/www.m3globalresearch.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/logo\/image\/","url":null,"contentUrl":null,"width":null,"height":null,"caption":"M3 Global Research"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/en-gb.facebook.com\/M3GlobalResearch\/","https:\/\/x.com\/M3GR_Community","https:\/\/www.instagram.com\/m3globalresearch","https:\/\/www.linkedin.com\/company\/10557915"]},{"@type":"Person","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/person\/1cfdc9643db265062879b6101de95df0","name":"Simone Guglielmi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/543a9507853330062cbff3a8ec7fdac833526c6115036f399b3123cb017b7d1a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/543a9507853330062cbff3a8ec7fdac833526c6115036f399b3123cb017b7d1a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/543a9507853330062cbff3a8ec7fdac833526c6115036f399b3123cb017b7d1a?s=96&d=mm&r=g","caption":"Simone Guglielmi"},"url":"https:\/\/www.m3globalresearch.com\/blog\/author\/sguglielmim3mr-com\/"}]}},"jetpack_featured_media_url":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2026\/06\/ARB-Based-Regimens-scaled.jpeg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/170880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/comments?post=170880"}],"version-history":[{"count":14,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/170880\/revisions"}],"predecessor-version":[{"id":170930,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/170880\/revisions\/170930"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/media\/170885"}],"wp:attachment":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/media?parent=170880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/categories?post=170880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/tags?post=170880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}